The use of DNA mismatch repair (MMR) immunohistochemistry (IHC) has expanded over recent years. It is now one of the recommended methods for Lynch syndrome screening in colorectal and endometrial carcinoma and has utility in the prediction of tumour response to checkpoint inhibitor therapy. This webinar will provide a basic refresher of the science behind DNA MMR proteins and the staining patterns most commonly encountered in DNA MMR IHC, including some common practical issues.
This event will take place at 1pm and last approximately 1 hour.
This meeting is worth 1 CPD point (self credited).